Abstract
To rein in cost, payers are exploring bundled payment, which aggregates fees for a range of services into a single prospective payment. While under bundled payment providers would have incentives to reduce cost, they might also withhold more expensive care that patients prefer. We explore how bundled payment could be aligned with a benefit design that would encourage patients’ consideration of cost without jeopardizing access to the most expensive treatments. Least-costly-alternative approaches allow patient choice but might deter patients from choosing more expensive care by exposing them to potentially large out-of-pocket payments. A novel “shared-savings supplement” would reward patients for choosing the least costly alternative with a supplemental cash disbursement and thus allow them to share in any cost savings. This cash incentive for the least-costly-alternative allows a reduction of the out-of-pocket payment for the expensive alternative. Thus, patients would still have the option of the more expensive therapy while facing only a modest out-of-pocket cost. Such benefit modifications could be aligned with bundled payment by splitting the responsibility for the incremental cost of more expensive care between patients and their providers.
References
Bach, P. B. (2009) “Limits on Medicare’s Ability to Control Rising Spending on Cancer Drugs,” New England Journal of Medicine, 360:626–633.10.1056/NEJMhpr0807774Search in Google Scholar
Bach, P. B., J. N. Mirkin and J. J. Luke (2011) “Episode-Based Payment For Cancer Care: A Proposed Pilot For Medicare,” Health Affairs, 30:3500–3509.10.1377/hlthaff.2010.0752Search in Google Scholar
Baicker, Katherine and Dana Goldman (2011) “Patient Cost-Sharing and Healthcare Spending Growth,” Journal of Economic Perspectives, 25(2):47–68.10.1257/jep.25.2.47Search in Google Scholar
Cassidy, A. (2011) “Health Policy Brief: Putting Limits on ‘Medigap’,” Health Affairs, September 13, 2011.Search in Google Scholar
Centers for Medicare & Medicaid Services (2011). “Medicare Shared Savings Program: Accountable Care Organizations (CMS-1345-P).” Accessed at: http://www.gpo.gov/fdsys/pkg/FR-2011-04-07/pdf/2011-7880.pdf (accessed April 29, 2013).Search in Google Scholar
Chernew, M. E., L. Sabik, A. Chandra and J. P. Newhouse (2010) “Ensuring the Fiscal Sustainability of Health Care Reform,” New England Journal of Medicine, 362:1–3.10.1056/NEJMp0910194Search in Google Scholar
Chernew, M., W. Encinosa and R. Hirth (2000) “Optimal Health Insurance: The Case of Observable, Severe Illness,” Journal of Health Economics, 19(5):585–609.10.1016/S0167-6296(00)00061-8Search in Google Scholar
Ellis, R. P. and T. G. McGuire (1990) “Optimal Payment Systems for Health Services,” Journal of Health Economics, 9:375–396.10.1016/0167-6296(90)90001-JSearch in Google Scholar
Feigenbaum, Susan (1992) “‘Body Shop’ Economics: What’s Good for Our Cars May be Good for Our Health,” CATO Regulation: The Review of Business & Government 15(4). http://www.cato.org/pubs/regulation/regv15n4/reg15n4b.html (accessed May 2, 2010).Search in Google Scholar
Feldman, Roger (2008) How to Fix Medicare: Let’s Pay Patients, not Physicians. Washington, DC: American Enterprise Institute for Public Policy Research.Search in Google Scholar
Gianfrancesco, Frank G. (1983) “A Proposal for Improving the Efficiency of Medical Insurance,” Journal of Health Economics 2(2):176–184.10.1016/0167-6296(83)90007-3Search in Google Scholar
Hussey, P. S., M. S. Ridgely and M. B. Rosenthal (2011) “The PROMETHEUS Bundled Payment Experiment: Slow Start Shows Problems In Implementing New Payment Models,” Health Affairs, 30:112116–112124.10.1377/hlthaff.2011.0784Search in Google Scholar
Kaiser Family Foundation (2010) Medicare: A Primer. Available at: http://www.kff.org/medicare/upload/7615-03.pdf (accessed April 29, 2013).Search in Google Scholar
Kaiser Family Foundation (2011). Projecting income and assets. Publication #8172. Available at: http://www.kff.org/medicare/upload/8172.pdf.Search in Google Scholar
Medicare Payment Advisory Commission (2010) Report to the Congress: Aligning Incentives in Medicare. Available at: http://www.medpac.gov/documents/jun10_entirereport.pdf (accessed April 29, 2013).Search in Google Scholar
Medicare Payment Advisory Commission (2011) Report to the Congress: Medicare and the Health Care Delivery System. Available at: http://www.medpac.gov/documents/Jun11_EntireReport.pdf (accessed April 29, 2013).Search in Google Scholar
Neumann, P. J., J. A. Palmer, E. Nadler, C. Fang and P. Ubel (2010) “Cancer Therapy Costs Influence Treatment: A National Survey of Oncologists,” Health Affairs, 29:196–202.10.1377/hlthaff.2009.0077Search in Google Scholar
Pauly, Mark V. (1971) “Indemnity Insurance for Health Care Efficiency,” Economic and Business Bulletin, 24(1):53–59.Search in Google Scholar
Pearson, S. D. and P. B. Bach (2010) “How Medicare Could Use Comparative Effectiveness Research in Deciding on New Coverage and Reimbursement,” Health Affairs, 29(10): 1796–1804.10.1377/hlthaff.2010.0623Search in Google Scholar
Perlroth, D. J., D. P. Goldman and A. M. Garber (2010) “The Potential Impact of Comparative Effectiveness Research on U.S. Health Care Expenditures,” Demography, 47:S173–S190.Search in Google Scholar
Schrag, D. and M. Hanger (2007) “Medical Oncologists’ Views on Communicating with Patients About Chemotherapy Costs: A Pilot Survey,” Journal of Clinical Oncology, 25:233–237.10.1200/JCO.2006.09.2437Search in Google Scholar
Streeter, S. B., L. Schwartzberg, N. Husain and M. Johnsrud (2011) “Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions,” Journal of Oncology Practice, 46s–51s.10.1200/JOP.2011.000316Search in Google Scholar
United States Congress (2010) Patient Protection and Affordable Care Act, January 5, 2010, Public law 111–148, section 3210. Washington, DC. Available at: http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf (accessed April 29, 2013).Search in Google Scholar
Van Eenwyk, J., J. S. Campo and E. M. Ossiander (2002) “Socioeconomic and Demographic Disparities in Treatment for Carcinomas of the Colon and Rectum,” Cancer, 95:39–46.10.1002/cncr.10645Search in Google Scholar
Zeckhauser, Richard (1970) “Medical Insurance: A Case Study of the Tradeoff Between Risk Spreading and Appropriate Incentives,” Journal of Economic Theory, Elsevier, 2(1):10–26.10.1016/0022-0531(70)90010-4Search in Google Scholar
©2013 by Walter de Gruyter Berlin Boston
Articles in the same Issue
- Masthead
- Masthead
- The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files
- Price Shopping in Consumer-Directed Health Plans
- The Effect of Comprehensive Smoking Bans in European Workplaces
- Should Global Health be Tailored Toward the Rich? Altruism and Efficient R&D for Neglected Diseases
- Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors
- Integrating Patient Incentives with Episode-Based Payment
- Better Quality of Care or Healthier Patients? Hospital Utilization by Medicare Advantage and Fee-for-Service Enrollees
- AIDS and Conflict: Micro Evidence from Burundi1)
- Measuring the Financial Exposure from Medical Care Spending Among Families with Employer Sponsored Insurance
- Why are Testing Rates so Low in Sub-Saharan Africa? Misconceptions and Strategic Behaviors
Articles in the same Issue
- Masthead
- Masthead
- The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files
- Price Shopping in Consumer-Directed Health Plans
- The Effect of Comprehensive Smoking Bans in European Workplaces
- Should Global Health be Tailored Toward the Rich? Altruism and Efficient R&D for Neglected Diseases
- Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors
- Integrating Patient Incentives with Episode-Based Payment
- Better Quality of Care or Healthier Patients? Hospital Utilization by Medicare Advantage and Fee-for-Service Enrollees
- AIDS and Conflict: Micro Evidence from Burundi1)
- Measuring the Financial Exposure from Medical Care Spending Among Families with Employer Sponsored Insurance
- Why are Testing Rates so Low in Sub-Saharan Africa? Misconceptions and Strategic Behaviors